Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Ultrashort echo time MRI ‘valuable’ for assessing pulmonary diseases in COVID-19 patients

The approach was on-par with CT scan quality at detecting some of the most common findings associated with the disease, including lesions and ground-glass opacities, experts wrote in the Journal of MRI.

Thumbnail

Lung ultrasound ‘substantially’ influences treatment for pregnant women with COVID-19

Treatment for COVID‐19 was either started or changed in 87.5% of the patients based on LUS findings, doctors reported in the Journal of Ultrasound in Medicine.

Thumbnail

PET/CT helps track response, progression in patients with difficult-to-treat prostate cancer

The new study included more than 120 men with metastatic castration-resistant prostate cancer, and was presented during the American Society of Clinical Oncology 2020 virtual meeting.

Thumbnail

FDA approves first PET agent for tau imaging

Tauvid was developed by Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, and offers clinicians a new type of brain scan to use in patients being evaluated for Alzheimer's disease.

Thumbnail

Children with COVID-19 often have negative chest CT findings, study shows

In a subset of children with positive imaging findings, however, bilateral and lower lobe-predominant ground-glass opacities are common.

Thumbnail

FDA greenlights PET imaging agent for breast cancer

The radiopharmaceutical—Cerianna—is the first F-18 agent approved for use in patients with recurrent or metastatic breast cancer.

Thumbnail

Novel ‘double-contrast’ method spots small tumors on MRI

University of California, Davis, researchers believe their new probe could help detect very small, early stage tumors.

Thumbnail

NIH hands out $3.5M grant for PET-based research into depression

Stony Brook University investigators seek to quantify the precise degree of brain inflammation in those with the illness and ultimately hope to suggest novel treatments.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.